Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.

You Z, Shi XB, DuRaine G, Haudenschild D, Tepper CG, Lo SH, Gandour-Edwards R, de Vere White RW, Reddi AH.

Cancer Res. 2006 Jan 1;66(1):175-83.

2.

Androgen axis in prostate cancer.

Culig Z, Bartsch G.

J Cell Biochem. 2006 Oct 1;99(2):373-81. Review.

PMID:
16598769
3.

Molecular regulation of androgen action in prostate cancer.

Dehm SM, Tindall DJ.

J Cell Biochem. 2006 Oct 1;99(2):333-44. Review.

PMID:
16518832
4.

Interleukin-6 regulation of prostate cancer cell growth.

Culig Z, Steiner H, Bartsch G, Hobisch A.

J Cell Biochem. 2005 Jun 1;95(3):497-505. Review.

PMID:
15838876
5.

Interleukin-6 and prostate cancer progression.

Smith PC, Hobisch A, Lin DL, Culig Z, Keller ET.

Cytokine Growth Factor Rev. 2001 Mar;12(1):33-40. Review.

PMID:
11312117
7.

Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins.

Watson RW, Fitzpatrick JM.

BJU Int. 2005 Dec;96 Suppl 2:30-4. Review.

8.

Approaches to the treatment of patients with hormone-sensitive prostate cancer.

DiPaola RS.

Semin Oncol. 1999 Oct;26(5 Suppl 17):24-7. Review.

PMID:
10604265
9.
10.

Signaling for the caspases: their role in prostate cell apoptosis.

Coffey RN, Watson RW, Fitzpatrick JM.

J Urol. 2001 Jan;165(1):5-14. Review.

PMID:
11125352
11.

XIAP as target for therapeutic apoptosis in prostate cancer.

Devi GR.

Drug News Perspect. 2004 Mar;17(2):127-34. Review.

PMID:
15098067
12.

[Preclinical models of prostate cancer].

Fizazi K, Navone NM.

Bull Cancer. 2005 Feb;92(2):129-41. Review. French.

13.

Vitamin A and apoptosis in prostate cancer.

Zhang XK.

Endocr Relat Cancer. 2002 Jun;9(2):87-102. Review.

14.

Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.

Sobel RE, Sadar MD.

J Urol. 2005 Feb;173(2):360-72. Review.

PMID:
15643173
15.

Cancer gene therapy utilizing interleukin-13 receptor alpha2 chain.

Kawakami K.

Curr Gene Ther. 2005 Apr;5(2):213-23. Review.

PMID:
15853729
16.

[Calcium-dependent programmed cell death in prostate cancer].

Shuba IaM, Prevars'ka N, Skryma R.

Fiziol Zh. 2004;50(4):128-41. Review. Ukrainian.

PMID:
15460038
17.

The role of neuropeptide processing enzymes in endocrine (prostate) cancer: EC 3.4.24.15 (EP24.15).

Swanson TA, Kim SI, Myers M, Pabon A, Philibert KD, Wang M, Glucksman MJ.

Protein Pept Lett. 2004 Oct;11(5):471-8. Review.

PMID:
15544568
18.

RAS pathways in prostate cancer - mediators of hormone resistance?

Whitaker HC, Neal DE.

Curr Cancer Drug Targets. 2010 Dec;10(8):834-9. Review.

PMID:
20718703
19.

Resistance to apoptosis in prostate cancer cells.

Howell SB.

Mol Urol. 2000 Fall;4(3):225-9;discussion 231. Review.

PMID:
11062378
20.

Proinflammatory cytokine interleukin-6 in prostate carcinogenesis.

Culig Z.

Am J Clin Exp Urol. 2014 Oct 2;2(3):231-8. eCollection 2014. Review.

Supplemental Content

Support Center